After a single administration of CAR-T, the enhancement of tumor luciferase signal was significantly decreased in the BxPC-3 model on days 14 and 21, indicating significant suppression of CEA++ pancreatic cancer growth due to CAR-T therapy. The gene discussed is CEACAM5; the disease is familial pancreatic carcinoma.